Inventor · disambiguated record
Yvette Miata Petersen
Also filed as: PETERSEN YVETTE MIATA
8 granted patents·4 pending applications·132 citations·filing 2006–2024
89Inventor score
Top patents by PatentIndex Score
12 records- 0194US8642727B2Selective glucagon-like-peptide-2 (GLP-2) analoguesLARSEN BJARNE DUE·Filed 2007·Granted Feb 4, 2014·37 cites·6 claims
- 0294US7563770B2Glucagon-like-peptide-2 (GLP-2) analoguesZEALAND PHARMA AS·Filed 2006·Granted Jul 21, 2009·25 cites·2 claims
- 0393US9580487B2Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analoguesZEALAND PHARMA AS·Filed 2015·Granted Feb 28, 2017·12 cites·20 claims
- 0493US7745403B2Methods of treating chemotherapy-induced diarrhea/mucositis using glucagon-like-peptide-2(GLP-2)analoguesZEALAND PHARMA AS·Filed 2006·Granted Jun 29, 2010·18 cites·2 claims
- 0592US8163696B2Treatment of inflammatory bowel disease using glucagon-like-peptide-2 (GLP-2) analoguesLARSEN BJARNE DUE·Filed 2009·Granted Apr 24, 2012·16 cites·4 claims
- 0691US8263552B2Glucagon-like-peptide-2 (GLP-2) analoguesLARSEN BJARNE DUE·Filed 2009·Granted Sep 11, 2012·13 cites·8 claims
- 0789US9125882B2Glucagon-like-peptide-2 (GLP-2) analoguesLARSEN BJARNE DUE·Filed 2012·Granted Sep 8, 2015·10 cites·11 claims
- 0883US2025122260A1Glucagon-like-peptide-2 (glp-2) analoguesZEALAND PHARMA AS·Filed 2024·Application pending·0 cites
- 0971US10092648B2Selective glucagon-like-peptide-2 (GLP-2) analoguesZEALAND PHARMA AS·Filed 2014·Granted Oct 9, 2018·1 cites·17 claims
- 1067US2021309708A1Glucagon-like-peptide-2 (glp-2) analoguesZEALAND PHARMA AS·Filed 2021·Application pending·0 cites
- 1162US2019330295A1Glucagon-like-peptide-2 (glp-2) analoguesZEALAND PHARMA AS·Filed 2019·Application pending·0 cites
- 1262US2017137487A1Glucagon-like-peptide-2 (glp-2) analoguesZEALAND PHARMA AS·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →